Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

KKR Genetic Disorder L.P. — BridgeBio Pharma, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / KKR Genetic Disorder L.P.

KKR Genetic Disorder L.P.

10% owner at BridgeBio Pharma, Inc. · on record since Jun 27, 2019

Insider trading activity of KKR Genetic Disorder L.P.

Transactions on record: 2; since Jun 1, 2020

Open-market buys: 0

Open-market sells: 2; $288.4M

Companies traded: 1; last filing Feb 17, 2021

Figures computed from official regulatory filings — methodology.

Companies where KKR Genetic Disorder L.P. has traded

BridgeBio Pharma, Inc.2 tx · $288.4M · Feb 17, 2021

Track record of KKR Genetic Disorder L.P.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of KKR Genetic Disorder L.P.

Co-insiders of KKR Genetic Disorder L.P.

AGUIAR ERICBridgeBio Pharma, Inc.
Apuli MaricelBridgeBio Pharma, Inc.
Cook Jennifer E.BridgeBio Pharma, Inc.
Dachille Douglas A.BridgeBio Pharma, Inc.
DANIELS RONALD JBridgeBio Pharma, Inc.
Ellis AndreaBridgeBio Pharma, Inc.
HALVORSEN OLE ANDREASBridgeBio Pharma, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

HASSAN FREDBridgeBio Pharma, Inc.

HENDERSON MICHAEL THOMASBridgeBio Pharma, Inc.

HOMCY CHARLES JBridgeBio Pharma, Inc.

KKR & Co. L.P.BridgeBio Pharma, Inc.

KKR Fund Holdings L.P.BridgeBio Pharma, Inc.

KKR Genetic Disorder GP LLCBridgeBio Pharma, Inc.

KKR Group Co. Inc.BridgeBio Pharma, Inc.

KKR Group Holdings Corp.BridgeBio Pharma, Inc.

KKR Management Holdings CorpBridgeBio Pharma, Inc.

KKR Management Holdings L.P.BridgeBio Pharma, Inc.

KKR Management LLCBridgeBio Pharma, Inc.

KRAVIS HENRY RBridgeBio Pharma, Inc.

Kumar NeilBridgeBio Pharma, Inc.

Lo AndrewBridgeBio Pharma, Inc.

MCCORMICK FRANKBridgeBio Pharma, Inc.

MOMTAZEE JAMES CBridgeBio Pharma, Inc.

Ott David C.BridgeBio Pharma, Inc.

ROBERTS GEORGE RBridgeBio Pharma, Inc.

Satvat Ali J.BridgeBio Pharma, Inc.

SAUNDERS BRENT LBridgeBio Pharma, Inc.

SCHELLER RICHARD HBridgeBio Pharma, Inc.

Scott Randal WBridgeBio Pharma, Inc.

Shabet Rose SharonBridgeBio Pharma, Inc.

Sinha UmaBridgeBio Pharma, Inc.

STEPHENSON BRIAN CBridgeBio Pharma, Inc.

Stolz Brian M.BridgeBio Pharma, Inc.

Trimarchi ThomasBridgeBio Pharma, Inc.

Turtle CameronBridgeBio Pharma, Inc.

Valantine HannahBridgeBio Pharma, Inc.

Viking Global Equities Master Ltd.BridgeBio Pharma, Inc.

VIKING GLOBAL INVESTORS LPBridgeBio Pharma, Inc.

Viking Global Opportunities GP LLCBridgeBio Pharma, Inc.

Viking Global Opportunities Illiquid Investments Sub-Master LPBridgeBio Pharma, Inc.

Viking Global Opportunities Parent GP LLCBridgeBio Pharma, Inc.

Viking Global Opportunities Portfolio GP LLCBridgeBio Pharma, Inc.

VIKING GLOBAL PERFORMANCE LLCBridgeBio Pharma, Inc.

Viking Long Fund GP LLCBridgeBio Pharma, Inc.

Viking Long Fund Master Ltd.BridgeBio Pharma, Inc.

YAU YI CHINGBridgeBio Pharma, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
BridgeBio Pharma, Inc.	Feb 17, 2021	Sell	-3,450,000	60.47 USD	$208.6M	SEC
BridgeBio Pharma, Inc.	Jun 1, 2020	Sell	-2,389,690	33.39 USD	$79.8M	SEC